Guardant Health (GH) Treasury Shares (2017 - 2026)

Guardant Health has disclosed Treasury Shares across 1 years of filings, most recently posting $45.0 million for Q3 2025.

• Treasury Shares for Q1 2026 came in at $7.1 million, up 630.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.1 million (up 630.95% YoY), and the FY2025 annual result was $1.3 million, down 81.76% from the prior year.
• Treasury Shares came in at $7.1 million for Q1 2026 at Guardant Health, up from $1.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $7.9 million in Q2 2025 to a low of $341713.0 in Q4 2022.
• The 5-year median for Treasury Shares is $2.3 million (2022), against an average of $3.2 million.
• Across the five-year window, Treasury Shares slumped 81.76% in 2025 and soared 630.95% in 2026, its largest moves.
• Guardant Health's Treasury Shares stood at $341713.0 in 2022, then surged by 561.6% to $2.3 million in 2023, then jumped by 210.53% to $7.0 million in 2024, then plunged by 81.76% to $1.3 million in 2025, then surged by 457.19% to $7.1 million in 2026.
• The last three Treasury Shares figures came in at $45.0 million (Q3 2025), $45.0 million (Q2 2025), and $45.0 million (Q1 2025), per Business Quant data.